{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:26Z","timestamp":1787009966628,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Fibromyalgia is a nociplastic pain disorder with musculoskeletal pain. Current treatments are frequently ineffective and produce unwanted side effects. Antinociceptive and neuroprotective activities of scopoletin have not yet been tested in fibromyalgia models. A mouse model of fibromyalgia was created by subcutaneous reserpine (1\u2005mg\/kg\/d) administration for 3 successive days. Scopoletin treatment was initiated on day 4. Behavioral tests included the tests for mechanical allodynia (von Frey test), thermal hyperalgesia (Hargreaves test), and grip strength, as well as the forced swim test and the open field test. Toxicity was examined with the rotarod test, locomotor activity, catalepsy, body weight, and temperature. Reference drugs were pregabalin and duloxetine. Reserpine-induced significant mechanical allodynia (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.001), thermal hyperalgesia (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.001), muscle weakness (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.001), depressive-like behavior (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.001), and anxiety-like behavior (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.01). Scopoletin (100\u2005mg\/kg) significantly reversed mechanical allodynia at 1\u2005h posttreatment (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.001) and improved grip strength (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.01) and thermal latency (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.01). It also reduced immobility in the FST by 37\u2005\u00b1\u20058% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.01) and decreased thigmotaxis in the open field test (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20050.01). Unlike duloxetine, scopoletin significantly attenuated both depressive and anxiety-like behaviors. No significant changes in locomotor coordination, body weight, temperature, or catalepsy were observed (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u20050.05). Scopoletin demonstrated significant antinociceptive, antidepressant, and anxiolytic effects in a reserpine-induced fibromyalgia model.\n                  <\/jats:p>","DOI":"10.1097\/fbp.0000000000000874","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:01:28Z","timestamp":1772791288000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of scopoletin as a potential therapeutic agent in fibromyalgia: evidence from a reserpine-induced mouse model"],"prefix":"10.1097","volume":"37","author":[{"given":"Yousra","family":"Bseiso","sequence":"first","affiliation":[{"name":"Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badriyah S.","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.A.","family":"Aljabali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Gammoh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad E.","family":"Rabeh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Jerash University, Jerash"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad M.","family":"Rabi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Jerash University, Jerash"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam","family":"Qnais","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahim","family":"Alqudah","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"R1-20260306","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.lfs.2018.11.029","article-title":"Diosmetin as a novel transient receptor potential vanilloid 1 antagonist with antinociceptive activity in mice.","volume":"216","author":"Adamante","year":"2019","journal-title":"Life Sci"},{"key":"R2-20260306","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s10067-022-06129-8","article-title":"Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.","volume":"41","author":"Alberti","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R3-20260306","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00213-024-06639-0","article-title":"Scopoletin mitigates maternal separation-induced anxiety-like and depression-like behaviors in male mice through modulation of the Sirt1\/NF-\u03baB pathway.","volume":"241","author":"Alqudah","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"R4-20260306","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jpain.2011.12.009","article-title":"Predictors of clinical pain in fibromyalgia: examining the role of sleep.","volume":"13","author":"Anderson","year":"2012","journal-title":"J Pain"},{"key":"R5-20260306","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/znc-2021-0193","article-title":"Scopoletin: a review of its source, biosynthesis, methods of extraction, and pharmacological activities.","volume":"77","author":"Antika","year":"2022","journal-title":"Z Naturforsch C J Biosci"},{"key":"R6-20260306","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ijcp.12757","article-title":"Fibromyalgia: management strategies for primary care providers.","volume":"70","author":"Arnold","year":"2016","journal-title":"Int J Clin Pract"},{"key":"R7-20260306","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2018.10.006","article-title":"THC and gabapentin interactions in a mouse neuropathic pain model.","volume":"144","author":"Atwal","year":"2019","journal-title":"Neuropharmacology"},{"key":"R8-20260306","doi-asserted-by":"crossref","first-page":"rkab015","DOI":"10.1093\/rap\/rkab015","article-title":"The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients.","volume":"5","author":"Atzeni","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"R9-20260306","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/23328940.2023.2167444","article-title":"Morphological study of the postnatal hippocampal development in the TRPV1 knockout mice.","volume":"10","author":"Boros","year":"2023","journal-title":"Temperature (Austin, Tex.)"},{"key":"R10-20260306","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1007\/s12035-020-01996-1","article-title":"Relevance of mitochondrial dysfunction in the reserpine-induced experimental fibromyalgia model.","volume":"57","author":"Brum","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R11-20260306","doi-asserted-by":"crossref","first-page":"107959","DOI":"10.1016\/j.pharmthera.2021.107959","article-title":"Animal models of fibromyalgia: what is the best choice?","volume":"230","author":"Brum","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R12-20260306","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2019.06.023","article-title":"Kinins and their B1 and B2 receptors are involved in fibromyalgia-like pain symptoms in mice.","volume":"168","author":"Brusco","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"R13-20260306","doi-asserted-by":"crossref","first-page":"173870","DOI":"10.1016\/j.ejphar.2021.173870","article-title":"Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice.","volume":"895","author":"Brusco","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R14-20260306","doi-asserted-by":"crossref","first-page":"8263463","DOI":"10.1155\/2016\/8263463","article-title":"Antihyperalgesic effect of hesperidin improves with diosmin in experimental neuropathic pain.","volume":"2016","author":"Carballo-Villalobos","year":"2016","journal-title":"Biomed Res Int"},{"key":"R15-20260306","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R16-20260306","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11916-016-0556-x","article-title":"Fibromyalgia pathogenesis and treatment options update.","volume":"20","author":"Chinn","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"R17-20260306","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions.","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"R18-20260306","first-page":"169","article-title":"Oxidative stress and mitochondrial dysfunction in fibromyalgia.","volume":"31","author":"Cordero","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"R19-20260306","doi-asserted-by":"crossref","first-page":"104673","DOI":"10.1016\/j.neuint.2020.104673","article-title":"Involvement of TRPV1 and the efficacy of \u03b1-spinasterol on experimental fibromyalgia symptoms in mice.","volume":"134","author":"Fischer","year":"2020","journal-title":"Neurochem Int"},{"key":"R20-20260306","doi-asserted-by":"crossref","first-page":"1268464","DOI":"10.3389\/fphar.2024.1268464","article-title":"Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity.","volume":"15","author":"Gao","year":"2024","journal-title":"Front Pharmacol"},{"key":"R21-20260306","doi-asserted-by":"crossref","first-page":"16593","DOI":"10.1039\/C9RA06056A","article-title":"Butein, isoliquiritigenin, and scopoletin attenuate neurodegeneration via antioxidant enzymes and SIRT1\/ADAM10 signaling pathway.","volume":"10","author":"Gay","year":"2020","journal-title":"RSC Adv"},{"key":"R22-20260306","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/j.pain.0000000000000735","article-title":"We do not need a third mechanistic descriptor for chronic pain states! Not yet.","volume":"158","author":"Granan","year":"2016","journal-title":"Pain"},{"key":"R23-20260306","doi-asserted-by":"crossref","first-page":"74","DOI":"10.9734\/jpri\/2021\/v33i331164","article-title":"Scopoletin ameliorates lipopolysaccharide induced neuroinflammation, oxidative stress and cognitive dysfunction in mice: a mechanistic study.","volume":"33","author":"Gursahani","year":"2021","journal-title":"J Pharm Res Int"},{"key":"R24-20260306","doi-asserted-by":"crossref","first-page":"1675957","DOI":"10.1155\/2020\/1675957","article-title":"Coumarins as modulators of the Keap1\/Nrf2\/ARE signaling pathway.","volume":"2020","author":"Hassanein","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"R25-20260306","doi-asserted-by":"crossref","first-page":"559962","DOI":"10.3389\/fnins.2020.00923","article-title":"Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review.","volume":"14","author":"Hepsomali","year":"2020","journal-title":"Front Neurosci"},{"key":"R26-20260306","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pop.2018.02.008","article-title":"Fibromyalgia in primary care.","volume":"45","author":"Higgs","year":"2018","journal-title":"Prim Care"},{"key":"R27-20260306","doi-asserted-by":"crossref","first-page":"2242074","DOI":"10.1155\/2022\/2242074","article-title":"Electroacupuncture reduces fibromyalgia pain by attenuating the HMGB1, S100B, and TRPV1 signalling pathways in the mouse brain.","volume":"2022","author":"Hsiao","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R28-20260306","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1080\/10408398.2022.2057914","article-title":"Flavonoids for depression and anxiety: a systematic review and meta-analysis.","volume":"63","author":"Jia","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R30-20260306","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1007\/s12035-025-04814-8","article-title":"Improvement in the cognitive function in chronic pain: therapeutic potential of the endocannabinoid system.","volume":"62","author":"Karimi-Haghighi","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R31-20260306","doi-asserted-by":"crossref","first-page":"2633105520937693","DOI":"10.1177\/2633105520937693","article-title":"Scopoletin: antiamyloidogenic, anticholinesterase, and neuroprotective potential of a natural compound present in argyreia speciosa roots by in vitro and in silico study.","volume":"15","author":"Kashyap","year":"2020","journal-title":"Neurosci Insights"},{"key":"R32-20260306","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice.","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"R33-20260306","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2014.09.035","article-title":"Reduction of intraepidermal nerve fiber density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.","volume":"347","author":"Kosmidis","year":"2014","journal-title":"J Neurol Sci"},{"key":"R34-20260306","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.5352\/JLS.2015.25.12.1377","article-title":"Anti-inflammatory effect of scopoletin in RAW264.7 macrophages.","volume":"25","author":"Lee","year":"2015","journal-title":"J Life Sci"},{"key":"R35-20260306","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00281-018-0672-2","article-title":"Neurogenic inflammation in fibromyalgia.","volume":"40","author":"Littlejohn","year":"2018","journal-title":"Semin Immunopathol"},{"key":"R36-20260306","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia.","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R37-20260306","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia.","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"R38-20260306","first-page":"67","article-title":"The role of GABA neurotransmitter in the human central nervous system, physiology, and pathophysiology.","volume":"22","author":"Ochoa-de la Paz","year":"2021","journal-title":"Rev Mex Neurocienc"},{"key":"R39-20260306","doi-asserted-by":"crossref","first-page":"102094","DOI":"10.1016\/j.npep.2020.102094","article-title":"Phoneutria nigriventer Tx3-3 peptide toxin reduces fibromyalgia symptoms in mice.","volume":"85","author":"Pedron","year":"2021","journal-title":"Neuropeptides"},{"key":"R40-20260306","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12017-025-08869-7","article-title":"Scopoletin attenuates reserpine-induced pain-depression dyad in mice via modulation of inflammation, oxidative stress, and monoaminergic pathways.","volume":"27","author":"Qnais","year":"2025","journal-title":"Neuromolecular Med"},{"key":"R41-20260306","doi-asserted-by":"crossref","first-page":"122954","DOI":"10.1016\/j.lfs.2024.122954","article-title":"Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management.","volume":"355","author":"Rahman","year":"2024","journal-title":"Life Sci"},{"key":"R42-20260306","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/ijabmr.IJABMR_58_19","article-title":"Effect of chrysin on mechanical hyperalgesia in chronic constriction injury-induced neuropathic pain in rat model.","volume":"10","author":"Rayiti","year":"2020","journal-title":"Int J Appl Basic Med Res"},{"key":"R43-20260306","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41583-022-00611-7","article-title":"TRP channels: a journey towards a molecular understanding of pain.","volume":"23","author":"Rosenbaum","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"R44-20260306","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jpp\/rgab047","article-title":"Modulation of multiple cellular signalling pathways as targets for anti-inflammatory and anti-tumorigenesis action of Scopoletin.","volume":"74","author":"Sakthivel","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"R45-20260306","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment.","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R47-20260306","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.3390\/molecules29163957","article-title":"The phytochemical, quercetin, attenuates nociceptive and pathological pain: neurophysiological mechanisms and therapeutic potential.","volume":"29","author":"Takeda","year":"2024","journal-title":"Molecules"},{"key":"R48-20260306","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.0b013e3181e0f7b3","article-title":"Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy.","volume":"74","author":"\u00dc\u00e7eyler","year":"2010","journal-title":"Neurology"},{"key":"R49-20260306","first-page":"1343","article-title":"Attenuation of reserpine\u2011induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol.","volume":"19","author":"Yao","year":"2019","journal-title":"Exp Ther Med"},{"key":"R50-20260306","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.1038\/s41598-017-17715-1","article-title":"Involvement of TRPM2 and TRPV1 channels on hyperalgesia, apoptosis and oxidative stress in rat fibromyalgia model: protective role of selenium.","volume":"7","author":"Y\u00fcksel","year":"2017","journal-title":"Sci Rep"},{"key":"R51-20260306","doi-asserted-by":"crossref","first-page":"18988","DOI":"10.3390\/molecules201018988","article-title":"Validated LC-MS\/MS method for the determination of scopoletin in rat plasma and its application to pharmacokinetic studies.","volume":"20","author":"Zeng","year":"2015","journal-title":"Molecules"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:01:35Z","timestamp":1772791295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000874","relation":{},"ISSN":["0955-8810","1473-5849"],"issn-type":[{"value":"0955-8810","type":"print"},{"value":"1473-5849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"2025-11-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}